BLR Pharma

Active

Private limited companyfounded 2024active for 2 yearsChemin de la Maie-è l'Maî(ML) 16, 5020 Namur, BelgiumKBO/BCE: BE 1012.884.490

Summary

BLR Pharma has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €23,210 and a net result of €6,604. Its solvency ranks better than 32% of 39,121 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

BLR PharmaActiveChecked score 94/100

Risk analysis Report Compare

History

BLR Pharma was incorporated on 28 August 2024 as a private limited company by one natural person, with a starting capital of €2,000.¹² Since 2024, Bastien LEGRAIN has served as director of the company.² The company has filed 2 sets of annual accounts, the latest for financial year 2025.³

Acts, filings and financial milestones

All 3Gazette 1Filings 2

Next filing, financial year 2026, expected by 31-07-2027

2026

17-06

NBB filing Annual accounts filed

financial year 2025 · micro format

2025

20-06

NBB filing Annual accounts filed

financial year 2024 · micro format

2024

30-08

Gazette deed Incorporation

Appointment: Bastien LEGRAIN (director) · Permanent representative: Bastien LEGRAIN · Founder10 facts ▸

Founder, Bastien LEGRAIN
Incorporation, 22-08-2024
Founding capital, €2,000
Capital
Registered office clause, “5020 Malonne, Chemin de la Maie-è l'Maî 16” (deed in French)
Board rule, 1
Director appointment, Bastien LEGRAIN (director (not named in the articles))
Director compensation, “sauf décision contraire de l'assemblée générale, gratuit” (deed in French)
Permanent representative, Bastien LEGRAIN
Pre-incorporation commitments, “takeover, tous les engagements ainsi que les obligations qui en résultent, et toutes les activités entreprises” (deed in French)

Gazette deedNBB filing

1 of 1 deed read